Menu
| Koska J, Osredkar T, D'Souza K, Sands M, Sinha S, Zhang W, Meyer C, Reaven PD. Effects of saxagliptin on adipose tissue inflammation and vascular function in overweight and obese people: a placebo-controlled study. Diabet Med. 2019 Nov;36(11):1399-1407. doi: 10.1111/dme.13889. Epub 2019 Jan 21. PubMed PMID: 30580454. |
| Zhou JJ, Koska J, Bahn G, Reaven P. Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial. Diab Vasc Dis Res. 2019 Mar;16(2):178-185. doi: 10.1177/1479164119827598. PubMed PMID: 31014099. |
| Koska J, Saremi A, Howell S, Bahn G, De Courten B, Ginsberg H, Beisswenger PJ, Reaven PD. Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes. Diabetes Care. 2018 Mar;41(3):570-576. doi: 10.2337/dc17-1740. Epub 2017 Dec 5. PubMed PMID: 29208654; PubMed Central PMCID: PMC5829965. |
| Koska J, Lopez L, D'Souza K, Osredkar T, Deer J, Kurtz J, Salbe AD, Harman SM, Reaven PD. Effect of liraglutide on dietary lipid-induced insulin resistance in humans. Diabetes Obes Metab. 2018 Jan;20(1):69-76. doi: 10.1111/dom.13037. Epub 2017 Aug 10. PubMed PMID: 28605158. |
| Koska J, Ozias MK, Deer J, Kurtz J, Salbe AD, Harman SM, Reaven PD. A human model of dietary saturated fatty acid induced insulin resistance. Metabolism. 2016 Nov;65(11):1621-1628. doi: 10.1016/j.metabol.2016.07.015. Epub 2016 Aug 5. PubMed PMID: 27733250. |
Interested in learning more about the Foundation and its operations? Head on over to the Career tab or send us an email!
